AI for personalized medicine and drug development through image-based quantification of single-cell phenotypes, to ensure that every cancer patient gets the best possible treatment. Acquired by Exscientia.
Next-generation care, enabled through a combination of online consultation with productivity tools and built with system-wide working at its core for 5x faster patient care.
Unlocking the power of your health data through a personal medicine platform that combines digital health check-ups, detailed analytics and actionable plans in one platform.
Improving care outcomes with a single collaborative platform for clinicians and nurses, streamlining patient onboarding, clinical workflows and protocols, self-help programs, and more.
Building a drug discovery engine with precision fermentation to find and scale new-to-nature medicines, addressing the unmet medical needs in pain, addiction, and depression.
A new, hypothesis-free approach for drug discovery for the deadliest cancers, using genetic computational systems analysis, powered by polymathic AI.
Solving protein design for biologists using powerful prediction algorithms and AI design suggestions to get tailored thermostability, activity, and specificity in record time.
Machine learning, metabolomics, and robotics, merged into a drug discovery platform that integrates datasets of anthropological, biological, and chemical information from medicinal plants.
Redefining the status quo of gene expression for drug development - through the foundational redesign of synthetic DNA instructions powered by AI and proprietary intron advantage.
Enabling healthcare providers to make better treatment decisions through a platform that makes liquid biopsy tests compliant, easy and cheap
Unlocking the true potential of gene therapy through a novel, best-in-class DNA modality that allows safe, effective, and flexible in vivo correction of genetic diseases.
Solving the carer bottleneck through digital infrastructure for carers and patients, to streamline treatments, support families, care at home, and without time pressure.
Life-saving cancer treatments with mRNA, designed by combining the latest research with synthetic biology and machine learning.
Delivering end-to-end clinical trials for health and biotech pioneers through a full-service platform integrating study design, recruitment, trial management and data management.
Connecting patients, researchers, entrepreneurs and funders to unlock the full potential of science by enabling fast collaboration and knowledge-sharing on the world’s first IP-NFT marketplace.
Access to the right information at the right time for patients suffering from genetic diseases, through personalized genetic testing and a fast and accurate AI-driven variant interpretation platform.
A new paradigm for cardiopulmonary care through a human-centric virtual care platform that empowers and engages people living with complex heart and lung conditions.
A paradigm shift in proteomics - a fundamentally new way of analyzing proteins through nanopore sensing for biomedicine, healthcare and industrial applications.
Unlocking RNA therapeutics for the masses by moving mRNA manufacturing where it originates, living cells, for 10x better manufacturing, scalable and cost-effective.
New insights from genomic data for precision medicine, enabled by a platform for easy data orchestration and workflow creation.
Mapping the druggable transcriptome to create a discovery platform that powers first-in-class small molecule programs targeted at classically undruggable proteins and non-coding RNA targets
Extending healthy life-expectancy for women, starting with digital therapeutics for menopause that combines data, clinical best practice and behaviour.
Better usage of health data through a single API that integrates 500+ devices, including all wearables and at-home kits, to integrate crucial information in hours, not months.
